Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: Results from the DIVA study group

Infection

Volumn 42, Issue 1, 2014, Pages 61-71

  Svicher, V ^a   Alteri, C ^a   Montano, M ^a   Nori, A ^a   D'Arrigo, R ^b   Andreoni, M ^a   Angarano, G ^c   Antinori, A ^b   Antonelli, G ^d   Allice, T ^e   Bagnarelli, P ^f   Baldanti, F ^g   Bertoli, A ^a   Borderi, M ^h   Boeri, E ⁱ   Bon, I ^h   Bruzzone, B ^j   Barresi, R ^j   Calderisi, S ^j   Callegaro, A P ^k   Capobianchi, M R ^b   Gargiulo, F ^l   Castelli, F ^l,m   Cauda, R ⁿ   Ceccherini Silberstein, F ^a   Clementi, M ⁱ   Chirianni, A ^o   Colafigli, M ⁿ   D'Arminio Monforte, A ^p   De Luca, A ^q   Di Biagio, A ^j   Di Nicuolo, G ^o   Di Perri, G ^e   Di Santo, F ^a   Fadda, G ⁿ   Galli, M ^r   Gennari, W ^s   Ghisetti, V ^e   Costantini, A ^f   Gori, A ^t   Gulminetti, R ^g   Leoncini, F ^u   Maffongelli, G ^a   Maggiolo, F ^k   Maserati, R ^g   Mazzotta, F ^v   Meini, G ^w   Micheli, V ^r   Monno, L ^c   Mussini, C ^s   Nozza, S ^x   Paolucci, S ^g   Palu G ^y   Parisi, S ^y   Parruti, G ^z   Pignataro, A R ⁱ   Quirino, T ^aa   Re, M C ^h   Rizzardini, G ^r   Sanguinetti, M ⁿ   Santangelo, R ⁿ   Scaggiante, R ^y   Sterrantino, G ^u   Turriziani, O ^d   Vatteroni, M L ^ab   Viscoli, C ^j   Vullo, V ^d   Zazzi, M ^w   Lazzarin, A ^x   Perno, C F ^a   more..

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^g FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^j UNIVERSITY OF GENOA   (Italy)

^k OSPEDALI RIUNITI   (Italy)

^l Ospedali Civili di Brescia   (Italy)

^m UNIVERSITY OF BRESCIA   (Italy)

ⁿ CATHOLIC UNIVERSITY   (Italy)

^o AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^p SAN PAOLO HOSPITAL   (Italy)

^q UNIVERSITY HOSPITAL OF SIENA   (Italy)

^r UNIVERSITY OF MILAN   (Italy)

^s UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^t SAN GERARDO HOSPITAL   (Italy)

^u CAREGGI UNIVERSITY HOSPITAL   (Italy)

^v SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^w UNIVERSITY OF SIENA   (Italy)

^x SAN RAFFAELE HOSPITAL   (Italy)

^y UNIVERSITY OF PADOVA   (Italy)

^z Pescara General Hospital   (Italy)

^aa BUSTO ARSIZIO HOSPITAL   (Italy)

^ab UNIVERSITY OF PISA   (Italy)

more..

Author keywords

CCR5 antagonists; Geno2pheno; HIV DNA; Tropism; Virologically suppressed patients

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1 CORECEPTOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RECEPTOR;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENOTYPING TECHNIQUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; TROPISM;

ADULT; DNA, VIRAL; FEMALE; GENOTYPING TECHNIQUES; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PROVIRUSES; RECEPTORS, HIV; SEQUENCE ANALYSIS, DNA; VIRAL TROPISM; VIRUS INTERNALIZATION;

EID: 84898546832     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0510-3     Document Type: Article

References (18)

1. Vandekerckhove LP, Wensing AM, Kaiser R, Brun-Vézinet F, Clotet B, De Luca A, Dressler S, Garcia F, Geretti AM, Klimkait T, Korn K, Masquelier B, Perno CF, Schapiro JM, Soriano V, Sönnerborg A, Vandamme AM, Verhofstede C, Walter H, Zazzi M, Boucher CA. European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis. 2011;11:394-407.
2. Obermeier M, Symons J, Wensing AM. HIV population genotypic tropism testing and its clinical significance. Curr Opin HIV AIDS. 2012;7:470-7.
3. Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Sandres-Sauné K, Cuzin L, Marchou B, Massip P, Izopet J. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism. AIDS. 2008;22:F11-6.
4. Seclén E, Del Mar González M, de Mendoza C, Soriano V, Poveda E. Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia. J Antimicrob Chemother. 2010;65: 1493-6.
5. Seclén E, Garrido C, Midel MG, González-Lahoz J, de Mendoza C, Soriano V, Poveda E. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists. J Antimicrob Chemother. 2010;65:1486-92.
6. Svicher V, D'Arrigo R, Alteri C, Andreoni M, Angarano G, Antinori A, Antonelli G, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bonn I, Bruzzone B, Callegaro AP, Cammarota R, Canducci F, Ceccherini-Silberstein F, Clementi M, Monforte AD, De Luca A, Di Biagio A, Di Gianbenedetto S, Di Perri G, Di Pietro M, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori A, Leoncini F, Maggiolo F, Maserati R, Mazzotta F, Micheli V, Meini G, Monno L, Mussini C, Nozza S, Paolucci S, Parisi S, Pecorari M, Pizzi D, Quirino T, Re MC, Rizzardini G, Santangelo R, Soria A, Stazi F, Sterrantino G, Turriziani O, Viscoli C, Vullo V, Lazzarin A, Perno CF, OSCAR Study Group. Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. New Microbiol. 2010;33:195-206.
7. Verhofstede C, Brudney D, Reynaerts J, Vaira D, Fransen K, De Bel A, Seguin-Devaux C, De Wit S, Vandekerckhove L, Geretti AM. Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA. HIV Med. 2011;12:544-52.
8. Cooper DA, Heera J, Goodrich J, Tawadrous M, Saag M, Dejesus E, Clumeck N, Walmsley S, Ting N, Coakley E, Reeves JD, Reyes-Teran G, Westby M, Van Der Ryst E, Ive P, Mohapi L, Mingrone H, Horban A, Hackman F, Sullivan J, Mayer H. Maraviroc versus efavirenz, both in combination with zidovudinelamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection. J Infect Dis. 2010;201:803-13.
9. Svicher V, Alteri C, Montano M, D'Arrigo R, Andreoni M, Angarano G, Antinori A, Antonelli G, Allice T, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bon I, Bruzzone B, Callegaro AP, Capobianchi MR, Carosi G, Cauda R, Ceccherini-Silberstein F, Clementi M, Chirianni A, Colafigli M, Monforte AD, De Luca A, Di Biagio A, Di Nicuolo G, Di Perri G, Di Pietro M, Di Santo F, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori C, Gori A, Gulminetti R, Leoncini F, Maffongelli G, Maggiolo F, Manca G, Gargiulo F, Martinelli C, Maserati R, Mazzotta F, Meini G, Micheli V, Monno L, Mussini C, Narciso P, Nozza S, Paolucci S, Pal G, Parisi S, Parruti G, Pignataro AR, Pollicita M, Quirino T, Re MC, Rizzardini G, Santangelo R, Scaggiante R, Sterrantino G, Turriziani O, Vatteroni ML, Vecchi L, Viscoli C, Vullo V, Zazzi M, Lazzarini A, Perno CF, DIVA group. Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. New Microbiol. 2012;35:17-25.
10. Aquaro S, Perno CF. Assessing the relative efficacy of antiretroviral activity of different drugs on macrophages. Methods Mol Biol. 2005;304:445-53.
11. Viard JP, Burgard M, Hubert JB, Aaron L, Rabian C, Pertuiset N, Lourenço M, Rothschild C, Rouzioux C. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS. 2004;18:45-9. (Pubitemid 38402316)
12. Bellecave P., Paredes R, Soriano V, Marcelin AG, Geretti AM, Svicher V, Descamps D, Camacho RJ, Kaiser R, Masquelier B. Determination of HIV-1 tropism using DNA samples and its impact on virological response to maraviroc containing regimens. In: Conf Retroviruses and Opportunistic Infection. Seattle. 2012. Abstract # 716, page 347 of the abstract book
13. Soulié C, Fourati S, Lambert-Niclot S, Malet I, Wirden M, Tubiana R, Valantin MA, Katlama C, Calvez V, Marcelin AG. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists. J Antimicrob Chemother. 2010;65:749-51.
14. Symons J, Vandekerckhove L, Paredes R, Verhofstede C, Bellido R, Demecheleer E, van Ham PM, van Lelyveld SF, Stam AJ, van Versendaal D, Nijhuis M, Wensing AM. Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice. Clin Microbiol Infect. 2012;18:606-12.
15. de Luca AM, Meini G, Rossetti B, Bianco C, Di Giambenedetto S, Sighinolfi L, Monno L, Castagna A, Capobianchi MR, d'Arminio Monforte A, Zazzi M. HIV-1 co-receptor tropism evolution in naive patients undergoing successful ART: concordance of DNA vs. RNA and triplicate versus singlicate population sequencing. Rev Antivir Ther Infect Dis. 2012:18.
16. Santoro MM, Armenia D, Fabeni L, Santoro M, Gori C, Forbici F, Svicher V, Bertoli A, Dori L, Surdo M, Balestra E, Palamara G, Girardi E, Angarano G, Andreoni M, Narciso P, Antinori A, Ceccherini-Silberstein F, Perno CF. The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients. Clin Microbiol Infect. 2012;18:289-98.
17. Yang H, Wu H, Hancock G, Clutton G, Sande N, Xu X, Yan H, Huang X, Angus B, Kuldanek K, Fidler S, Denny TN, Birks J, McMichael A, Dorrell L. Antiviral inhibitory capacity of CD8 + T cells predicts the rate of CD4 ? T-cell decline in HIV-1 infection. J Infect Dis. 2012;15:552-61.
18. Saunders KO, Ward-Caviness C, Schutte RJ, Freel SA, Overman RG, Thielman NM, Cunningham CK, Kepler TB, Tomaras GD. Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage. Cell Immunol. 2011;266:154-64.